Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1440]
News [2204]
Articles [39]
Editorials [5]
Conferences [149]
elearning [0]
NICE recommends brentuximab vedotin, in combination with chemotherapy, as frontline treatment for a rare type of lymphoma
NICE recommends brentuximab vedotin, in combination with chemotherapy, as frontline treatment for a rare type of...
Early clinical trial tests treatment strategy for pancreatic cancer
Early clinical trial tests treatment strategy for pancreatic cancer
American Cancer Society updates guideline for HPV vaccination
American Cancer Society updates guideline for HPV vaccination
FDA approves oral combination of decitabine and cedazuridine for myelodysplastic syndromes
FDA approves oral combination of decitabine and cedazuridine for myelodysplastic syndromes
FDA approves avelumab for urothelial carcinoma maintenance treatment
FDA approves avelumab for urothelial carcinoma maintenance treatment
FDA approves first-line immunotherapy for patients with MSI-H/dMMR metastatic colorectal cancer
FDA approves first-line immunotherapy for patients with MSI-H/dMMR metastatic colorectal cancer
FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf for HER2-positive breast cancer
FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf for HER2-positive breast cancer
FDA approves pembrolizumab for cutaneous squamous cell carcinoma
FDA approves pembrolizumab for cutaneous squamous cell carcinoma
Researchers find that common cancer treatments don't worsen coronavirus infection
Researchers find that common cancer treatments don't worsen coronavirus infection
FDA grants accelerated approval to tazemetostat for follicular lymphoma
FDA grants accelerated approval to tazemetostat for follicular lymphoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation